Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_assertion evidence source_evidence_literature NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_assertion SIO_000772 18387633 NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_assertion wasDerivedFrom befree-20140225 NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_assertion wasGeneratedBy ECO_0000203 NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.